a Selective Bcl-2 Inhibitor with Tuned Bcl-Xl Activity, Causes Myeloid Differentiation and Cell Death in Acute Myeloid Leukemia (AML)

被引:0
|
作者
Koenig, Kristin L. [1 ]
Brame, Colin [2 ]
Sher, Steven [1 ]
Beaver, Larry [1 ]
Cempre, Casey B. [1 ]
Williams, Katie [1 ]
Purcell, Matthew [2 ]
Harrington, Bonnie [3 ]
Chen, Yi [4 ]
Tan, Felai [4 ]
Anthony, Stephen P. [4 ]
Chen, Yu [4 ]
Shen, Yue [4 ]
Byrd, John C. [5 ]
Lapalombella, Rosa [6 ]
机构
[1] Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH USA
[2] Ohio State Univ, Columbus, OH USA
[3] Charles River Labs, Wilmington, NC USA
[4] Newave Pharmaceut Inc, Pleasanton, CA USA
[5] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[6] Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol, Columbus, OH USA
关键词
D O I
10.1182/blood-2022-170578
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
LP-118
引用
收藏
页码:9068 / 9069
页数:2
相关论文
共 50 条
  • [21] Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines
    Nuessler, V
    Stötzer, O
    Gullis, E
    Pelka-Fleischer, R
    Pogrebniak, A
    Gieseler, F
    Wilmanns, W
    LEUKEMIA, 1999, 13 (11) : 1864 - 1872
  • [22] Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity
    Hennessy, Edward J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (09) : 2105 - 2114
  • [23] Bcl-2 and Bcl-XL can differentially block chemotherapy-induced cell death
    Simonian, PL
    Grillot, DAM
    Nunez, G
    BLOOD, 1997, 90 (03) : 1208 - 1216
  • [24] The Bcl-2/Bcl-XL inhibitor ABT-737 promotes death of retinoblastoma cancer cells
    Allaman-Pillet, Nathalie
    Oberson, Anne
    Munier, Francis
    Schorderet, Daniel F.
    OPHTHALMIC GENETICS, 2013, 34 (1-2) : 1 - 13
  • [25] Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines
    V Nuessler
    O Stötzer
    E Gullis
    R Pelka-Fleischer
    A Pogrebniak
    F Gieseler
    W Wilmanns
    Leukemia, 1999, 13 : 1864 - 1872
  • [26] Control of apoptosis in AML by BCL-2 and BCL-XL:: Critical impact of cytogenetics.
    Andreeff, M
    Zhao, S
    Xie, Z
    Konopleva, M
    Estey, E
    Munsell, M
    Sanchez-Williams, G
    Kornblau, S
    Reed, J
    BLOOD, 1998, 92 (10) : 207B - 207B
  • [27] BCL-2 and BCL-XL restrict lineage choice during hematopoietic differentiation
    Haughn, L
    Hawley, RG
    Morrison, DK
    von Boehmer, H
    Hockenbery, DM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (27) : 25158 - 25165
  • [28] Subcellular distribution and function of Bcl-2 and Bcl-xL in the beta cell
    Luciani, D. S.
    Widenmaier, S.
    Yeung, J.
    McIntosh, C.
    Johnson, J. D.
    DIABETOLOGIA, 2008, 51 : S218 - S219
  • [29] RNA-DIRECTED SYNTHESIS OF BCL-2/BCL-XL PEPTIDE INHIBITOR
    Di Pisa, M.
    Seitz, O.
    JOURNAL OF PEPTIDE SCIENCE, 2016, 22 : S162 - S162
  • [30] A concise review of BCL-2 inhibition in acute myeloid leukemia
    Yogarajah, Meera
    Stone, Richard M.
    EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (02) : 145 - 154